ClinVar Miner

Submissions for variant NM_006996.3(SLC19A2):c.484C>T (p.Arg162Ter)

dbSNP: rs74315373
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV003555936 SCV004293791 pathogenic not provided 2023-09-13 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg162*) in the SLC19A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC19A2 are known to be pathogenic (PMID: 10391221, 10391223, 10874303). This variant is present in population databases (rs74315373, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with thiamine-responsive megaloblastic anemia syndrome (PMID: 10391221). ClinVar contains an entry for this variant (Variation ID: 5955). For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000006319 SCV000026501 pathogenic Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness 1999-07-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.